共 491 条
[1]
Tsilidis KK(2015)Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies BMJ 350 g7607-12
[2]
Kasimis JC(2015)Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies Obes. Rev. 16 1-1340
[3]
Lopez DS(2018)Metabolic reprogramming of natural killer cells in obesity limits antitumor responses Nat. Immunol. 19 1330-1419
[4]
Ntzani EE(2015)The clinical application of linagliptin in Asians Ther. Clin. Risk Manag 11 1409-E880
[5]
Ioannidis JP(2014)Dipeptidyl peptidase 4 inhibitor sitagliptin maintains beta-cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study J. Clin. Endocrinol. Metab. 99 E876-1486
[6]
O’Neill S(2010)Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation Endocrinology 151 1473-156
[7]
O’Driscoll L(2011)Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies Gastroenterology 141 150-341
[8]
Michelet X(2010)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Int. J. Surg. 8 336-613
[9]
Dyck L(1998)Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352 609-12
[10]
Hogan A(1996)Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin. Trials 17 1-768